The company’s US-based distributor Covis Pharmaceuticals will promote the products, manufactured and supplied by Sanofi, in the US.
Sanofi retains the rights for the products outside US.
Covis Pharma CEO Jack Davis said, "Covis will continue to supply consistent, top quality, branded pharmaceuticals, ensuring that patients receive the therapeutic care they need."
Terms of the agreement that obtained Hart-Scott-Rodino regulatory clearance in the US, were not revealed.